Investigation of GLP1-Receptor Agonists in Men With Prostate Cancer Taking Androgen Deprivation Therapy

ConditionProstate Cancer

Trial statusRecruiting

Trial phasePhase 4

Trial typeInterventional

Biological sexMale

Age18+

SponsorHamilton Health Sciences Corporation

About this trial

GAIN PC CONTROL is a study investigating Glucagon-Like Peptide-1 Receptor Agonists in men with prostate cancer who are being treated with androgen deprivation therapy.

Eligibility criteria

Qualifiers

Have a physician diagnosis of PC

Must be receiving or planned to receive ADT (gonadotropin releasing hormone agonist or antagonist ± androgen receptor pathway inhibitor)

Elevated BMI

≥30kg/m2 or

Disqualifiers

Type 1 diabetes

Taking a GLP-1 RA

<18 years of age

History of pancreatitis

Trial design

Treatments tested in this trial

Semaglutide Pen Injector

Treatment groups

20 Participants

are divided into 1 treatment group

Sponsors and collaborators

Hamilton Health Sciences Corporation

Lead sponsor

McMaster University

Collaborator

Source ClinicalTrials.gov